Biopharmaceutical companies
1 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Dec 22, 2022 by Noam Solomon · across every show →
Everything said about Biopharmaceutical companies, oldest first
Dec 22, 2022 positive
Solomon: Immunai generates commercial revenue from large biopharma partnerships
“First is that we are already working and making money by working with our partnerships you know, large Biopharmaceutical companies are paying us good money to help them further develop and improve the development of their drug candidates and other drugs.”